There were 508 press releases posted in the last 24 hours and 330,362 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
SELLAS Life Sciences Receives FDA Orphan Drug Designation for Galinpepimut-S (GPS) for Treatment of Multiple Myeloma (MM)

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image